UNSPSC 85621604: Removal of infusion device from endocrine gland, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of infusion device from endocrine gland, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0GPS33Z

UNSPSC 85621604 Removal of infusion device from endocrine gland, percutaneous approach (Commodity) shows little relevant recent activity for state and local procurement. The code nominally describes a surgical procedure, but the recent opportunities tagged under it encompass independent medical evaluations, occupational health surveillance, pharmacy benefit management, surgical care coordination, and temporary health professional staffing — activities that do not align with procurement of the specific endocrine-focused procedural service the code names. State and local bodies appear to be using this code to tag broader health services and staffing solicitations rather than discrete infusion-device removal procedures or related medical supplies and equipment.

The opportunities that do appear span different issuing bodies: the City of Phoenix Retirement Office (pension board disability evaluations), the City of Long Beach (surgical benefit carve-out networks), the Washington State Department of Transportation (occupational medical surveillance), Harris County Juvenile Probation Department (emergency and specialty medical services for youth in custody), Collier County Board of County Commissioners (pharmacy benefit management), and the County of Santa Clara Health System (temporary health professional staffing). These are scattered across Arizona, California, Florida, and Washington, with no geographic concentration. The most concrete opportunity is Phoenix's RFP 26001 for independent medical evaluation services due October 16, 2026, at $750,000 over five years — a service clearly unrelated to the code's nominal scope. The code does not signal active procurement of endocrine infusion-device removal services or supplies.